Advertisement

ADVERTISEMENT

treatment

Poll: Dermatologic and Rheumatologic Manifestations in IBD
Poll
Poll: Dermatologic and Rheumatologic Manifestations in IBD
09/08/2020
Which treatment-related manifestation has led you to change your therapeutic approach to patients with inflammatory bowel disease (IBD)? Let us know by taking our poll.
Which treatment-related manifestation has led you to change your therapeutic approach to patients with inflammatory bowel disease (IBD)? Let us know by taking our poll.
Which treatment-related...
09/08/2020
Advances in Inflammatory Bowel Disease Network
Treat-To-Target Approach for Inflammatory Bowel Disease
Conference Coverage
Treat-To-Target Approach for Inflammatory Bowel Disease
08/22/2020
Applying a systematic treat-to-target approach is effective for reducing the risk of long-term complications in patients with IBD, but incremental benefit must be evaluated. Siddarth Singh, MD, spoke about this topic at today’s AIBD 2020...
Applying a systematic treat-to-target approach is effective for reducing the risk of long-term complications in patients with IBD, but incremental benefit must be evaluated. Siddarth Singh, MD, spoke about this topic at today’s AIBD 2020...
Applying a systematic...
08/22/2020
Advances in Inflammatory Bowel Disease Network
Diagnosing and Managing C difficile Infection in Patients With IBD
Conference Coverage
Diagnosing and Managing C difficile Infection in Patients With IBD
07/29/2020
Even among patients without pre-existing gastrointestinal disease, Clostridioides difficile is often debilitating. In patients with inflammatory bowel disease, it can be very serious. Jessica Allegretti, MD, explained the steps to diagnosing...
Even among patients without pre-existing gastrointestinal disease, Clostridioides difficile is often debilitating. In patients with inflammatory bowel disease, it can be very serious. Jessica Allegretti, MD, explained the steps to diagnosing...
Even among patients without...
07/29/2020
Advances in Inflammatory Bowel Disease Network
Russell Cohen, MD, on Defining the Target to Treat in IBD
Videos
Russell Cohen, MD, on Defining the Target to Treat in IBD
07/25/2020
Russell Cohen, MD, reviews his presentation from the virtual AIBD regional meeting July 25 on defining the target to treat in inflammatory bowel disease.
Russell Cohen, MD, reviews his presentation from the virtual AIBD regional meeting July 25 on defining the target to treat in inflammatory bowel disease.
Russell Cohen, MD, reviews his...
07/25/2020
Advances in Inflammatory Bowel Disease Network
Stephen Hanauer, MD, on Positioning JAK Inhibitors in IBD
Videos
Stephen Hanauer, MD, on Positioning JAK Inhibitors in IBD
07/25/2020
He discusses the positioning of JAK inhibitors in the treatment of inflammatory bowel disease, which he presented at the virtual AIBD regional meeting July 25.
He discusses the positioning of JAK inhibitors in the treatment of inflammatory bowel disease, which he presented at the virtual AIBD regional meeting July 25.
He discusses the positioning of...
07/25/2020
Advances in Inflammatory Bowel Disease Network
Positioning Therapeutic Agents for IBD
Conference Coverage
Positioning Therapeutic Agents for IBD
07/24/2020
The many different classes of medications available for treating inflammatory bowel disease give gastroenterologists more options than ever before—and also more challenges in determining how to balance efficacy and safety. Miguel Regueiro,...
The many different classes of medications available for treating inflammatory bowel disease give gastroenterologists more options than ever before—and also more challenges in determining how to balance efficacy and safety. Miguel Regueiro,...
The many different classes of...
07/24/2020
Advances in Inflammatory Bowel Disease Network
Treating IBD Without TNFis and JAKs
Conference Coverage
Treating IBD Without TNFis and JAKs
07/24/2020
The treatment of inflammatory bowel disease has changed dramatically since the introduction of biologics and small molecule therapeutics. But does that mean older therapies no longer have any role? David Rubin, MD, offered his views at the...
The treatment of inflammatory bowel disease has changed dramatically since the introduction of biologics and small molecule therapeutics. But does that mean older therapies no longer have any role? David Rubin, MD, offered his views at the...
The treatment of inflammatory...
07/24/2020
Advances in Inflammatory Bowel Disease Network
Preview: Russell Cohen, MD, on Defining the Target to Treat in IBD
Videos
Preview: Russell Cohen, MD, on Defining the Target to Treat in IBD
07/23/2020
Dr Cohen, director of the Inflammatory Bowel Disease Center at UChicago Medicine, previews his talk for the virtual Advances in Inflammatory Bowel Disease regional meeting July 25.
Dr Cohen, director of the Inflammatory Bowel Disease Center at UChicago Medicine, previews his talk for the virtual Advances in Inflammatory Bowel Disease regional meeting July 25.
Dr Cohen, director of the...
07/23/2020
Advances in Inflammatory Bowel Disease Network
ANA Investigates Cannabis and Cannabinoids for MS Symptoms
Podcasts
ANA Investigates Cannabis and Cannabinoids for MS Symptoms
07/20/2020
Michelle Cameron, MD, PT, talks about the federal and state legalities surrounding cannabinoid use, how cannabinoids go through the FDA approval process, and how cannabinoids can be used to treat symptoms of multiple sclerosis.
Michelle Cameron, MD, PT, talks about the federal and state legalities surrounding cannabinoid use, how cannabinoids go through the FDA approval process, and how cannabinoids can be used to treat symptoms of multiple sclerosis.
Michelle Cameron, MD, PT, talks...
07/20/2020
Neurology
Ryan Ungaro, MD, on Treat-to-Target: Is It All About the Mucosa?
Videos
Ryan Ungaro, MD, on Treat-to-Target: Is It All About the Mucosa?
06/30/2020
Ryan Ungaro, MD, of the Icahn School of Medicine at Mt. Sinai in New York, gives a recap of his presentation on treat-to-target in IBD from the virtual Advances in Inflammatory Bowel Disease 2020 regional meeting on June 27.
Ryan Ungaro, MD, of the Icahn School of Medicine at Mt. Sinai in New York, gives a recap of his presentation on treat-to-target in IBD from the virtual Advances in Inflammatory Bowel Disease 2020 regional meeting on June 27.
Ryan Ungaro, MD, of the Icahn...
06/30/2020
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
November 6 ⁠–⁠ November 8
NEI Congress
November 7 ⁠–⁠ November 10
ECS
November 8 ⁠–⁠ November 10
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use